Not applicableActive Not RecruitingNCT04866680What this trial is testingPersonalized Circulating DNA Follow-up in Melanoma (PERCIMEL)Who this might be right forMelanoma Institut de Cancérologie de Lorraine 136
Large-scale testing (Phase 3)UnknownNCT00000124What this trial is testingCollaborative Ocular Melanoma Study (COMS)Who this might be right forChoroid NeoplasmsUveitis National Eye Institute (NEI)
Testing effectiveness (Phase 2)Study completedNCT01256359What this trial is testingDocetaxel With or Without AZD6244 in MelanomaWho this might be right forMelanoma University of Oxford 83
Testing effectiveness (Phase 2)Looking for participantsNCT07230613What this trial is testingNeo-adjuvant Immunotherapy in Patients With Localized MelanomaWho this might be right forCutaneous Melanoma, Stage IIIMucosal Melanoma UNICANCER 50
Early research (Phase 1)Study completedNCT04291079What this trial is testingSRK-181 Alone or in Combination With Anti-PD-(L)1 Antibody Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (DRAGON)Who this might be right forCancer Scholar Rock, Inc. 112
Not applicableUnknownNCT05744076What this trial is testingAnalysis of Circulating Exosomes in Melanoma PatientsWho this might be right forMelanoma Centre Hospitalier Universitaire de Besancon 150
Early research (Phase 1)Looking for participantsNCT07600476What this trial is testingA First-in-Human Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of KUP-101A in Patients With Selected Advanced Solid TumorsWho this might be right forCutaneous MelanomaMucosal MelanomaCutaneous Squamous Cell Carcinoma (CSCC)+2 more Kupando GmbH 21
Early research (Phase 1)Study completedNCT03021460What this trial is testingPembrolizumab and Ibrutinib in Treating Patients With Stage III-IV Melanoma That Cannot Be Removed by SurgeryWho this might be right forMetastatic MelanomaStage III Cutaneous Melanoma AJCC v7Stage IIIA Cutaneous Melanoma AJCC v7+4 more Mayo Clinic 20
Testing effectiveness (Phase 2)Ended earlyNCT01433991What this trial is testingE7050 in Combination With E7080 in Participants With Advanced Solid Tumors (Dose Escalation) and in Participants With Recurrent Glioblastoma or Unresectable Stage III or Stage IV Melanoma After Prior Systemic Therapy (Expansion Cohort and Phase 2)Who this might be right forAdvanced Solid Tumors Eisai Inc. 30
Large-scale testing (Phase 3)Study completedNCT03430297What this trial is testingA Randomized, Controlled, Multi-center, Phase III Clinical Study to Investigate Recombinant Humanized PD-1 Monoclonal Antibody Injection (JS001) Versus Dacarbazine as the 1st-line Therapy for Unresectable or Metastatic MelanomaWho this might be right forMetastatic MelanomaUnresectable Melanoma Shanghai Junshi Bioscience Co., Ltd. 256
Not applicableStudy completedNCT01444560What this trial is testingMiRNA Machinery in Melanoma, Melanoma Metastases and Benign Melanocytic NaeviWho this might be right forCutaneous MelanomaNevi Ruhr University of Bochum 21
Not applicableStudy completedNCT04035447What this trial is testingSymptom Management for YA Cancer SurvivorsWho this might be right forCancerYoung AdultPain+7 more Duke University 65
Testing effectiveness (Phase 2)Active Not RecruitingNCT06784648What this trial is testingDifferent Doses of BI-1607 in Combination With Pembrolizumab and Ipilimumab, in Participants With Unresectable or Metastatic MelanomaWho this might be right forMelanoma MetastaticMelanoma of SkinMelanoma BRAF V600E/K Mutated+7 more BioInvent International AB 35
Not applicableEnded earlyNCT02355574What this trial is testing5-year Study to Track Clinical Application of DecisionDx-Melanoma Gene Expression Profile Assay ResultsWho this might be right forCutaneous Melanoma Castle Biosciences Incorporated 301
Early research (Phase 1)Looking for participantsNCT05859074What this trial is testingMQ710 With and Without Pembrolizumab in People With Solid Tumor CancerWho this might be right forCutaneous Squamous Cell CarcinomaSCC - Squamous Cell CarcinomaBasal Cell Carcinoma+16 more Memorial Sloan Kettering Cancer Center 56
Testing effectiveness (Phase 2)Ended earlyNCT03300843What this trial is testingAbility of a Dendritic Cell Vaccine to Immunize Melanoma or Epithelial Cancer Patients Against Defined Mutated Neoantigens Expressed by the Autologous CancerWho this might be right forMelanomaGastrointestinal CancerBreast Cancer+2 more National Cancer Institute (NCI) 1
Early research (Phase 1)Study completedNCT01621490What this trial is testingPH 1 Biomarker Study of Nivolumab and Ipilimumab and Nivolumab in Combination With Ipilimumab in Advanced MelanomaWho this might be right forAdvanced MelanomaMetastatic Melanoma Bristol-Myers Squibb 170
Not applicableLooking for participantsNCT07555210What this trial is testingPilot Study of Bone Mineral Density Changes During Anti-PD-1 ImmunotherapyWho this might be right forBreast Cancer (Triple Negative Breast Cancer (TNBC))Renal Cell Carcinoma (Kidney Cancer)Melanoma (Skin Cancer)+5 more Jessica Mezzanotte Sharpe 25
Early research (Phase 1)Ended earlyNCT04116320What this trial is testingFocused Ultrasound Ablation and PD-1 Antibody Blockade in Advanced Solid TumorsWho this might be right forMelanomaBreast CancerMerkel Cell Carcinoma+10 more Craig L Slingluff, Jr 5
Early research (Phase 1)Study completedNCT01652547What this trial is testingA Phase I, Exploratory, Intra-patient Dose Escalation Study to Investigate the Preliminary Safety, Pharmacokinetics, and Anti-tumor Activity of Pasireotide (SOM230) s.c.Followed by Pasireotide LAR in Patients With Metastaticmelanoma or Metastatic Merkel Cell CarcinomaWho this might be right forMetastatic Melanoma and Merkel Cell Carcinoma Novartis Pharmaceuticals 10